RECRUITING

A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate and compare the effectiveness of active screening for SHD in asymptomatic outpatients referred for an ECG, using a combination of AI-ECG and FOCUS. Invites will be sent and participants enrolled electronically.

Official Title

Integrating Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening; Structural Cardiac Assessment with Networked AI-ECG & FOCUS (SCAN) Study

Quick Facts

Study Start:2025-03
Study Completion:2026-04
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06891222

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult patients (\>18 years of age)
  2. * Echocardiogram is not clinically indicated
  1. * Prior history of congenital or acquired SHD, as defined by the following
  2. 1. Aortic Stenosis:
  3. 2. Heart Failure
  4. 3. Left Ventricular Dysfunction
  5. 4. Cardiac Amyloidosis
  6. 5. Hypertrophic Cardiomyopathy (HCM)
  7. 6. Rheumatic Heart Disease
  8. 7. Congenital Heart Disease
  9. * Recent (within last 12 months) echocardiogram
  10. * Scheduled clinically indicated future echocardiogram
  11. * Inability to provide informed consent to participate in the study

Contacts and Locations

Study Contact

Catalina Paraschiv, M.D., Ph.D.
CONTACT
507-293-3800
Paraschiv.Catalina@mayo.edu
Gal Tsaban, M.D., Ph.D.
CONTACT
507-284-2129
Tsaban.Gal@mayo.edu

Principal Investigator

Gal Tsaban, M.D., Ph.D.
PRINCIPAL_INVESTIGATOR
Mayo Clinic

Study Locations (Sites)

Mayo Clinic
Rochester, Minnesota, 55905
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Gal Tsaban, M.D., Ph.D., PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03
Study Completion Date2026-04

Study Record Updates

Study Start Date2025-03
Study Completion Date2026-04

Terms related to this study

Additional Relevant MeSH Terms

  • Cardiac Disease